# PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

> **NCT02603185** · PHASE1 · UNKNOWN · sponsor: **Hemay Pharmaceutical PTY. LTD.** · enrollment: 82 (estimated)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Hemay007
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02603185
- **Lead sponsor:** Hemay Pharmaceutical PTY. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2017-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603185, "PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02603185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*